Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Captodiamine

Known as: 2-((p-(Butylthio)-alpha-phenylbenzyl)thio)-N,N-dimethylethylamine, 2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine, Captodiame 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
BACKGROUND Prolonged treatment with benzodiazepines is common practice despite clinical recommendations of short-term use… Expand
2013
2013
The putative antidepressant captodiamine is a 5-HT2c receptor antagonist and agonist at sigma-1 and D3 dopamine receptors, exerts… Expand
2004
2004
SUMMARY Background and objectives: Discontinuation of benzodiazepines can be associated with the emergence of a withdrawal… Expand
1999
1999
AbstractObjective: To compare the effects of lorazepam, a benzodiazepine-type anxiolytic agent, with those of captodiamine, a non… Expand
1960
1960
  • L. Abbott
  • Australian journal of dermatology
  • 1960
  • Corpus ID: 46499105
The drug chosen for trial was p-butylthiodiphenyl-methyl-2-dimethylaminoethyl sulphide hydrochloride, the approved name for which… Expand
1958
1957